VANCOUVER, BC, June 15, 2023 /PRNewswire/ – Numinus Wellness Inc. (“Numinus”), (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and evidence-based investigational psychedelic-assisted therapies, announced a partnership with the Multidisciplinary Association for Psychedelic Studies (MAPS), to support psychedelic experiential opportunities for practitioners as…

Source

Previous articleOptimi Health To Supply MDMA For Therapist Experiential Training Program at Numinus, Supported by MAPS
Next articleIbogaine’s Surge in Popularity Could Be a Huge Loss for the Gabonese People Unless We Shift Course